Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST fish allergy immunotherapy study
NL-OMON43811Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fish allergy and food allergy comparing mCyp c 1 SCIT with Placebo (2 arms). Primary endpoint: Change from baseline in fish protein reaction threshold. Started Feb 2016; status: active, not recruiting.
02
Drugs
mutant carp parvalbumin
03
Conditions
fish allergyfood allergy
Beyond the preview
Go deeper on NL-OMON43811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43811.